Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study.
J Clin Med. 2021 Nov 8;10(21):5207. doi: 10.3390/jcm10215207.
J Clin Med. 2021.
PMID: 34768726
Free PMC article.
Gender-Related Differences in Prodromal Multiple Sclerosis Characteristics: A 7-Year Observation Study.
Perwieniec J, Podwójcic K, Maluchnik M, Szeląg M, Walkiewicz D, Zakrzewski M, Droździkowska A, Kamiński B, Zasybska A, Wnuk M, Słowik A, Rejdak K.
Perwieniec J, et al. Among authors: zasybska a.
J Clin Med. 2021 Aug 26;10(17):3821. doi: 10.3390/jcm10173821.
J Clin Med. 2021.
PMID: 34501269
Free PMC article.
Item in Clipboard
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design.
Rejdak K, Fiedor P, Bonek R, Goch A, Gala-Błądzińska A, Chełstowski W, Łukasiak J, Kiciak S, Dąbrowski P, Dec M, Król ZJ, Papuć E, Zasybska A, Segiet A, Grieb P.
Rejdak K, et al. Among authors: zasybska a.
Contemp Clin Trials. 2022 May;116:106755. doi: 10.1016/j.cct.2022.106755. Epub 2022 Apr 4.
Contemp Clin Trials. 2022.
PMID: 35390511
Free PMC article.
Item in Clipboard
Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial.
Rejdak K, Fiedor P, Bonek R, Łukasiak J, Chełstowski W, Kiciak S, Dąbrowski P, Gala-Błądzińska A, Dec M, Papuć E, Zasybska A, Kaczor M, Grieb P; COV-PREVENT Study Group.
Rejdak K, et al. Among authors: zasybska a.
Eur J Neurol. 2024 Jan;31(1):e16045. doi: 10.1111/ene.16045. Epub 2023 Sep 14.
Eur J Neurol. 2024.
PMID: 37584095
Clinical Trial.
Item in Clipboard
Cite
Cite